JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

133.89

-1.33%↓

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	6.8M -8.1M
Продажби	33M 72M
EPS	-0.04
Марж на печалбата	-11.242
Служители	105
EBITDA	6.7M -5.4M

Дивиденти
By Dow Jones
Следващи печалби	19.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	67M 158M
Предишно отваряне	0
Предишно затваряне	0

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.01.2026 г., 23:51 ч. UTC

Печалби

Correction to Samsung Fourth-Quarter Net Profit Article

28.01.2026 г., 23:49 ч. UTC

Горещи акции

Stocks to Watch: Meta, IBM, Las Vegas Sands, Whirlpool

28.01.2026 г., 23:19 ч. UTC

Печалби

Samsung's Fourth-Quarter Net Profit Beats Consensus

28.01.2026 г., 22:43 ч. UTC

Печалби

Waste Management Logs Higher 4Q Profit as Revenue Rises

29.01.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Diller's Overture Came Before Warner Unveiled Split Plans, Source Says -- WSJ

29.01.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Warner Says CNN Wasn't and Isn't for Sale -- WSJ

29.01.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Barry Diller Told Warner Bros. Discovery He Is Interested in Buying CNN -- WSJ

29.01.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Barry Diller Approached Warner Bros. Discovery Last Year About Buying CNN, Sources Say -- WSJ

28.01.2026 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

28.01.2026 г., 23:30 ч. UTC

Пазарно говорене

Tesla to Use Car Factory for Robot Aims -- Market Talk

28.01.2026 г., 23:28 ч. UTC

Печалби

Microsoft's Earnings Surge, Elevated by Cloud Business -- 3rd Update

28.01.2026 г., 23:26 ч. UTC

Печалби

Meta Reports Record Sales, Massive Spending Hike on AI Buildout -- 2nd Update

28.01.2026 г., 23:21 ч. UTC

Печалби

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28.01.2026 г., 23:18 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28.01.2026 г., 22:58 ч. UTC

Печалби

Tesla to Invest $2 Billion in Elon Musk's xAI -- Update

28.01.2026 г., 22:48 ч. UTC

Пазарно говорене

Woodside Energy Has Form With Conservative Production Guidance -- Market Talk

28.01.2026 г., 22:45 ч. UTC

Печалби

Samsung Electronics 2025 Net KRW45.207T Vs. Net KRW34.451T >005930.SE

28.01.2026 г., 22:44 ч. UTC

Печалби

Samsung Electronics 2025 Oper Pft KRW43.601T Vs. Pft KRW32.726T >005930.SE

28.01.2026 г., 22:43 ч. UTC

Печалби

Samsung Electronics 2025 Rev KRW333.606T Vs. KRW300.871T >005930.SE

28.01.2026 г., 22:41 ч. UTC

Печалби

Горещи акции

Earnings in Focus Wednesday: Microsoft, Tesla, Meta, Starbucks -- WSJ

28.01.2026 г., 22:41 ч. UTC

Пазарно говорене

Rising AUD Typically Sees Australian Stocks Outperform -- Market Talk

28.01.2026 г., 22:41 ч. UTC

Печалби

Meta Stock Rises on Strong Earnings. Expenses Are Mounting. -- Barrons.com

28.01.2026 г., 22:40 ч. UTC

Печалби

Samsung Electronics 4Q Net Profit Beat FactSet-Compiled Consensus

28.01.2026 г., 22:39 ч. UTC

Печалби

Samsung Electronics 4Q Net KRW19.642T Vs. Net KRW7.754T >005930.SE

28.01.2026 г., 22:38 ч. UTC

Печалби

Samsung Electronics 4Q Oper Pft KRW20.074T Vs. Pft KRW6.493T >005930.SE

28.01.2026 г., 22:37 ч. UTC

Печалби

Samsung Electronics 4Q Rev KRW93.837T Vs. KRW75.788T >005930.SE

28.01.2026 г., 22:35 ч. UTC

Печалби

Microsoft Stock Falls Despite Earnings Beat. Cloud Growth Slowed Slightly. -- Barrons.com

28.01.2026 г., 22:26 ч. UTC

Пазарно говорене

Печалби

Meta's Rising CapEx is Fueled by High Pay for AI Workers -- Market Talk

28.01.2026 г., 22:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

28.01.2026 г., 22:20 ч. UTC

Пазарно говорене

Woodside Energy's Oil Assets Blamed for Guidance Miss -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.